{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:27:19Z","timestamp":1768897639534,"version":"3.49.0"},"reference-count":25,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,4]]},"DOI":"10.4269\/ajtmh.20-0531","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T07:01:11Z","timestamp":1597734071000},"page":"1938-1941","source":"Crossref","is-referenced-by-count":6,"title":["Targeting IL-27 and\/or IL-10 in Experimental Murine Visceral Leishmaniasis"],"prefix":"10.4269","volume":"103","author":[{"given":"Henry W.","family":"Murray","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Well Cornell Medical College, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur J Immunol"},{"key":"b2","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun"},{"key":"b3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/376510","article-title":"Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis","volume":"188","author":"Murray","year":"2003","journal-title":"J Infect Dis"},{"key":"b4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The immunobiology of interleukin-27","volume":"33","author":"Yoshida","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"b5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ni1207-1281","article-title":"IL-10 or not IL-10: that is the question","volume":"8","author":"Jankovic","year":"2007","journal-title":"Nat Immunol"},{"key":"b6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cei.13116","article-title":"IL-27: a double agent in the IL-6 family","volume":"193","author":"Jones","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"b7","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.4049\/jimmunol.0804024","article-title":"IL-17 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection","volume":"183","author":"Anderson","year":"2009","journal-title":"J Immunol"},{"key":"b8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2016.00478","article-title":"Interleukin-27 early impacts Leishmania infantum infection in mice and correlates with active visceral disease in humans","volume":"7","author":"Perez-Cabezas","year":"2016","journal-title":"Front Immunol"},{"key":"b9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2353\/ajpath.2006.050013","article-title":"Interleukin-27R (WSX-1\/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology","volume":"168","author":"Rosas","year":"2006","journal-title":"Am J Pathol"},{"key":"b10","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.4049\/jimmunol.0904019","article-title":"Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection","volume":"185","author":"Findlay","year":"2010","journal-title":"J Immunol"},{"key":"b11","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/IAI.00066-14","article-title":"Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium","volume":"81","author":"Dann","year":"2014","journal-title":"Infect Immun"},{"key":"b12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.01468-12","article-title":"Regulatory actions of toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver","volume":"81","author":"Murray","year":"2013","journal-title":"Infect Immun"},{"key":"b13","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/IAI.00490-08","article-title":"Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice","volume":"76","author":"Murray","year":"2008","journal-title":"Infect Immun"},{"key":"b14","doi-asserted-by":"crossref","first-page":"e00824-16","DOI":"10.1128\/IAI.00824-16","article-title":"Gamma interferon-regulated chemokines in Leishmania donovani infection in the liver","volume":"85","author":"Murray","year":"2017","journal-title":"Infect Immun"},{"key":"b15","doi-asserted-by":"crossref","first-page":"e1006640","DOI":"10.1371\/journal.ppat.1006640","article-title":"Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology","volume":"13","author":"Pyle","year":"2017","journal-title":"PLoS Pathog"},{"key":"b16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fcimb.2019.00120","article-title":"Leishmania braziliensis infection enhances toll-like receptors 2 and 4 expression and triggers TNF-\u03b1 and IL-10 production in human cutaneous leishmaniasis","volume":"9","author":"Polari","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"b17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.imbio.2014.11.006","article-title":"IL-27 enhances Leishmania amazonensis infection via ds-RNA dependent kinase (PKR) and IL-10 signalling","volume":"220","author":"Barreto-de-Souza","year":"2015","journal-title":"Immunobiology"},{"key":"b18","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.4049\/jimmunol.1101654","article-title":"TLR2-mediated production of IL-27 and chemokines by respiratory epithelial cells promotes bleomycin-induced pulmonary fibrosis in mice","volume":"187","author":"Kim","year":"2011","journal-title":"J Immunol"},{"key":"b19","doi-asserted-by":"crossref","first-page":"e1003293","DOI":"10.1371\/journal.ppat.1003293","article-title":"IL-27 receptor signaling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals","volume":"9","author":"Villegas-Mendez","year":"2013","journal-title":"PLoS Pathog"},{"key":"b20","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/IAI.00047-11","article-title":"Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens","volume":"79","author":"Cyktor","year":"2011","journal-title":"Infect Immun"},{"key":"b21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s40425-019-0770-2","article-title":"Mechanisms regulating PDL-1 expression on tumor and immune cells","volume":"7","author":"Chen","year":"2019","journal-title":"J ImmunoTher Cancer"},{"key":"b22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1:PDL-1\/2 pathway from discovery to clinical implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front Immunol"},{"key":"b23","doi-asserted-by":"crossref","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","article-title":"B7-H1 blockade increases survival of dysfunctional CD8+ T cells and confers protection against Leishmania donovani infections","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog"},{"key":"b24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fimmu.2017.01492","article-title":"Immune checkpoint targets for host-directed therapy to prevent and treat leishmaniasis","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Immunol"},{"key":"b25","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.celrep.2020.01.099","article-title":"Type I interferons suppress anti-parasitic immunity and can be targeted to improve treatment of visceral leishmaniasis","volume":"30","author":"Kumar","year":"2020","journal-title":"Cell Rep"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:42:28Z","timestamp":1611769348000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.20-0531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11,4]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.20-0531","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}